Jefferies Starts Coverage of SelectQuote (SLQT) with Hold Rating | SLQT Stock News

Author's Avatar
May 21, 2025
Article's Main Image

Jefferies has begun coverage of SelectQuote (SLQT, Financial), assigning a Hold rating and setting a price target of $2.75. The company enjoys a significant role within the Medicare Advantage supply chain, aided by a unified marketing strategy that is fueling growth in both its Medicare Advantage policies and health services, including SelectRx. However, Jefferies expresses concerns that temper its enthusiasm. These include SelectRx's pivot towards serving higher acuity clients, a recent lawsuit from the Department of Justice, challenges with cash conversion, and a complex balance sheet. These factors contribute to Jefferies' cautious stance.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.